Upload
others
View
3
Download
0
Embed Size (px)
Citation preview
Extended Use Dates Provided by PfizerExtended Use Dates to Assist with Sterile Water for Injection (small-volumevials in 10 mL, 20 mL, 50 mL and 100 mL presentations) ManufacturedIntermittent Supply Interruptions[October 11, 2018] Due to the intermittent supply interruptions of sterile water for injection, FDA is alerting healthcare professionals and patients of updated dates through which some sterile water for injection, manufactured byHospira, a Pfizer company, may be used beyond the manufacturer’s labeled expiration date. To help ensure patientsafety, these products should have been — and should continue to be — stored as labeled.
Based on stability data provided by Pfizer and reviewed by FDA, the following extended use dates are supported forspecific batches indicated in the tables below. Patients that have the batch numbers below will be able to use themthrough the corresponding new use dates to help with supply. As data become available, this list can continue toexpand.
FDA is not requiring or recommending that the identified batches in the following tables be relabeled with their newuse dates. However, if replacement product becomes available during the extension period, then the agency expectsthe lots in these tables will be replaced and properly disposed of as soon as possible.
Please see the recent FDA in Brief for more information, and contact CDER Drug Shortage Staff [email protected] (mailto:[email protected]) with questions regarding these tables.
NDC Number LOT # EXP. DATE NEW EXP. DATE
00409-4887-10 580074P 1-Oct-18 1-Oct-19
00409-4887-10 580084P 1-Oct-18 1-Oct-19
00409-4887-10 580094P 1-Oct-18 1-Oct-19
00409-4887-10 600104P 1-Dec-18 1-Dec-19
00409-4887-10 610104P 1-Jan-19 1-Jan-20
00409-4887-10 610124P 1-Jan-19 1-Jan-20
00409-4887-10 630034P 1-Feb-19 1-Feb-20
00409-4887-10 640064P 1-Feb-19 1-Feb-20
00409-4887-20 640174P 1-Feb-19 1-Feb-20
00409-4887-20 650214P 1-Feb-19 1-Feb-20
mailto:[email protected]
00409-4887-10 630044P 1-Mar-19 1-Mar-20
00409-4887-10 630064P 1-Mar-19 1-Mar-20
00409-4887-10 630104P 1-Mar-19 1-Mar-20
00409-4887-10 630154P 1-Mar-19 1-Mar-20
00409-4887-10 630144P 1-Mar-19 1-Mar-20
00409-4887-10 640014P 1-Mar-19 1-Mar-20
00409-4887-10 640054P 1-Mar-19 1-Mar-20
00409-4887-10 640074P 1-Mar-19 1-Mar-20
00409-4887-20 58427DK 10/1/2018 10/1/2019
00409-4887-50 58400DK 10/1/2018 10/1/2019
00409-4887-50 58401DK 10/1/2018 10/1/2019
00409-4887-50 58402DK 10/1/2018 10/1/2019
00409-4887-50 58403DK 10/1/2018 10/1/2019
00409-4887-50 58408DK 10/1/2018 10/1/2019
00409-4887-10 58157DK 10/1/2018 10/1/2019
00409-4887-10 58158DK 10/1/2018 10/1/2019
00409-4887-10 58159DK 10/1/2018 10/1/2019
00409-4887-10 58160DK 10/1/2018 10/1/2019
00409-4887-10 58246DK 10/1/2018 10/1/2019
00409-4887-10 58247DK 10/1/2018 10/1/2019
00409-4887-10 58250DK 10/1/2018 10/1/2019
00409-4887-10 58442DK 10/1/2018 10/1/2019
00409-4887-20 59002DK 11/1/2018 11/1/2019
00409-4887-20 59003DK 11/1/2018 11/1/2019
00409-4887-20 59102DK 11/1/2018 11/1/2019
00409-4887-20 59419DK 11/1/2018 11/1/2019
00409-4887-20 59420DK 11/1/2018 11/1/2019
00409-4887-10 59012DK 11/1/2018 11/1/2019
00409-4887-10 59013DK 11/1/2018 11/1/2019
00409-4887-10 59319DK 11/1/2018 11/1/2019
00409-4887-10 59349DK 11/1/2018 11/1/2019
00409-4887-10 59350DK 11/1/2018 11/1/2019
00409-4887-10 59351DK 11/1/2018 11/1/2019
00409-4887-10 59378DK 11/1/2018 11/1/2019
00409-4887-10 59379DK 11/1/2018 11/1/2019
00409-4887-10 59380DK 11/1/2018 11/1/2019
00409-4887-10 59381DK 11/1/2018 11/1/2019
00409-4887-20 60054DK 12/1/2018 12/1/2019
00409-4887-20 60055DK 12/1/2018 12/1/2019
00409-4887-20 60056DK 12/1/2018 12/1/2019
00409-4887-10 60015DK 12/1/2018 12/1/2019
00409-4887-10 60016DK 12/1/2018 12/1/2019
00409-4887-20 61005DK 1/1/2019 1/1/2020
00409-4887-20 61006DK 1/1/2019 1/1/2020
00409-4887-20 61007DK 1/1/2019 1/1/2020
00409-4887-20 61008DK 1/1/2019 1/1/2020
00409-4887-20 61010DK 1/1/2019 1/1/2020
00409-4887-20 61299DK 1/1/2019 1/1/2020
00409-4887-20 61366DK 1/1/2019 1/1/2020
00409-4887-20 61368DK 1/1/2019 1/1/2020
00409-4887-50 61099DK 1/1/2019 1/1/2020
00409-4887-50 61363DK 1/1/2019 1/1/2020
00409-4887-99 61276DK 1/1/2019 1/1/2020
00409-4887-99 61279DK 1/1/2019 1/1/2020
00409-4887-99 61280DK 1/1/2019 1/1/2020
00409-4887-10 61062DK 1/1/2019 1/1/2020
00409-4887-10 61063DK 1/1/2019 1/1/2020
00409-4887-10 61064DK 1/1/2019 1/1/2020
00409-4887-20 62018DK 2/1/2019 2/2/2020
00409-4887-20 62019DK 2/1/2019 2/2/2020
00409-4887-20 62418DK 2/1/2019 2/2/2020
00409-4887-50 62290DK 2/1/2019 2/2/2020
00409-4887-99 62316DK 2/1/2019 2/2/2020
00409-4887-99 62317DK 2/1/2019 2/2/2020
00409-4887-99 62318DK 2/1/2019 2/2/2020
00409-4887-99 62319DK 2/1/2019 2/2/2020
00409-4887-10 62228DK 2/1/2019 2/2/2020
00409-4887-10 62229DK 2/1/2019 2/2/2020
00409-4887-10 62230DK 2/1/2019 2/2/2020
00409-4887-20 63443DK 3/1/2019 3/1/2020
00409-4887-20 63444DK 3/1/2019 3/1/2020
00409-4887-20 63445DK 3/1/2019 3/1/2020
00409-4887-20 63446DK 3/1/2019 3/1/2020
00409-4887-50 63278DK 3/1/2019 3/1/2020
00409-4887-50 63279DK 3/1/2019 3/1/2020
00409-4887-50 63280DK 3/1/2019 3/1/2020
00409-4887-50 63462DK 3/1/2019 3/1/2020
00409-4887-50 63463DK 3/1/2019 3/1/2020
00409-4887-99 63170DK 3/1/2019 3/1/2020
00409-4887-99 63425DK 3/1/2019 3/1/2020
00409-4887-99 63426DK 3/1/2019 3/1/2020
Extended Use Dates to Assist with Sodium Bicarbonate Injection Shortage[September 27, 2018] This is to update the information posted here previously on 6/15/17, 6/23/17, 7/19/17,8/17/17, 11/9/2017, and 6/12/2018. Due to the ongoing critical shortage of injectable drugs used in critical care, FDAis alerting health care professionals and emergency responders of updated dates through which some of theseinjectable drugs, manufactured by Hospira Inc, a Pfizer company, may be used beyond the manufacturer’s labeledexpiration date. To help ensure patient safety, these products should have been — and should continue to be —stored as labeled.
Based on stability data provided by Pfizer and reviewed by FDA, the tables of specific lots with extended use dateshave been updated for the following products:
Sodium Bicarbonate Injection, USP 8.4% (1 mEq/mL); 50 mEq/50 mL Single Dose Glass Fliptop Vial (NDC 0409-6625-02)
Sodium Bicarbonate Injection, USP 8.4% (1 mEq/mL); 50 mEq/50 mL Single Dose Glass Fliptop Vial (NDC 0409-6625-25) LABELLED AS NOVAPLUS
Hospitals that have the following lot numbers in stock will be able to use them through the corresponding new usedates to help with supply. As data become available, this list can continue to expand.
FDA is not requiring or recommending that the identified lots in the following tables be relabeled with their new usedates. However, if replacement product becomes available during the extension period, then it is expected that thelots in these tables will be replaced and properly disposed of as soon as possible.
Please contact CDER Drug Shortage Staff at [email protected](https://www.fda.gov/Drugs/DrugSafety/DrugShortages/[email protected]) with questionsregarding these tables.
Sodium Bicarbonate Injection, USP 8.4% (1 mEq/mL); 50 mEq/50 mL Single Dose Glass Fliptop Vial (NDC0409-6625-02)
Product/ Lot Number
Manufacturer’s Original Expiry Date
New Use Date (beyond manufacturer’s originalexpiry date)
65197EV 1-May-2018 1-Oct-2018
https://www.fda.gov/Drugs/DrugSafety/DrugShortages/[email protected]
65200EV 1-May-2018 1-Oct-2018
65205EV 1-May-2018 1-Oct-2018
65206EV 1-May-2018 1-Oct-2018
65503EV 1-May-2018 1-Oct-2018
65504EV 1-May-2018 1-Oct-2018
67138EV 1-Jul-2018 1-Dec-2018
67139EV 1-Jul-2018 1-Dec-2018
67140EV 1-Jul-2018 1-Dec-2018
67141EV 1-Jul-2018 1-Dec-2018
67142EV 1-Jul-2018 1-Dec-2018
67248EV 1-Jul-2018 1-Dec-2018
67279EV 1-Jul-2018 1-Dec-2018
67280EV 1-Jul-2018 1-Dec-2018
67281EV 1-Jul-2018 1-Dec-2018
67282EV 1-Jul-2018 1-Dec-2018
67283EV 1-Jul-2018 1-Dec-2018
67284EV 1-Jul-2018 1-Dec-2018
68059EV 1-Aug-2018 1-Jan-2019
68192EV 1-Aug-2018 1-Jan-2019
68193EV 1-Aug-2018 1-Jan-2019
68194EV 1-Aug-2018 1-Jan-2019
68308EV 1-Aug-2018 1-Jan-2019
68309EV 1-Aug-2018 1-Jan-2019
68429EV 1-Aug-2018 1-Jan-2019
68430EV 1-Aug-2018 1-Jan-2019
68431EV 1-Aug-2018 1-Jan-2019
69006EV 1-Sep-2018 1-Feb-2019
69008EV 1-Sep-2018 1-Feb-2019
69180EV 1-Sep-2018 1-Feb-2019
69181EV 1-Sep-2018 1-Feb-2019
69182EV 1-Sep-2018 1-Feb-2019
69353EV 1-Sep-2018 1-Feb-2019
69354EV 1-Sep-2018 1-Feb-2019
69355EV 1-Sep-2018 1-Feb-2019
69356EV 1-Sep-2018 1-Feb-2019
69357EV 1-Sep-2018 1-Feb-2019
69358EV 1-Sep-2018 1-Feb-2019
69361EV 1-Sep-2018 1-Feb-2019
69362EV 1-Sep-2018 1-Feb-2019
69376EV 1-Sep-2018 1-Feb-2019
69379EV 1-Sep-2018 1-Feb-2019
69380EV 1-Sep-2018 1-Feb-2019
70143EV 1-Oct-2018 1-Mar-2019
70316EV 1-Oct-2018 1-Mar-2019
70317EV 1-Oct-2018 1-Mar-2019
70318EV 1-Oct-2018 1-Mar-2019
71055EV 1-Nov-2018 1-Apr-2019
71056EV 1-Nov-2018 1-Apr-2019
71058EV 1-Nov-2018 1-Apr-2019
71079EV 1-Nov-2018 1-Apr-2019
71080EV 1-Nov-2018 1-Apr-2019
71081EV 1-Nov-2018 1-Apr-2019
71154EV 1-Nov-2018 1-Apr-2019
71339EV 1-Nov-2018 1-Apr-2019
Sodium Bicarbonate Injection, USP 8.4% (1 mEq/mL); 50 mEq/50 mL Single Dose Glass Fliptop Vial (NDC0409-6625-25) LABELLED AS NOVAPLUS
Product/ Lot Number
Manufacturer’s Original Expiry Date
New Use Date (beyond manufacturer’s originalexpiry date)
70064EV 1-Oct-2018 1-Mar-2019
70186EV 1-Oct-2018 1-Mar-2019
70255EV 1-Oct-2018 1-Mar-2019
71110EV 1-Nov-2018 1-Apr-2019
Extended use dates to assist with Aminophylline injection intermittent supply interruptions
[Sept 12, 2018] Due to the intermittent supply interruptions of Aminophylline injection, FDA is alerting health careprofessionals and patients of updated dates through which some Aminophylline injection, manufactured by Hospira,a Pfizer company, may be used beyond the manufacturer’s labeled expiration date. To help ensure patient safety,these products should have been — and should continue to be — stored as labeled.
Based on stability data provided by Pfizer and reviewed by FDA, the following extended use dates are supported forspecific batches indicated in the tables below. Patients that have the batch numbers below will be able to use themthrough the corresponding new use dates to help with supply. As data become available, this list can continue toexpand.
FDA is not requiring or recommending that the identified batches in the following tables be relabeled with their newuse dates. However, if replacement product becomes available during the extension period, then the agency expectsthe lots in these tables will be replaced and properly disposed of as soon as possible.
Please see the recent FDA in Brief for more information, and contact CDER Drug Shortage Staff [email protected] (mailto:[email protected]) with questions regarding these tables.
NDC NUMBER LOT # MFG. DATE EXP DATE NEW EXP DATE
00409-5921-01 76328DK 4/12/2017 10/1/2018 2/1/2019
00409-5921-01 76329DK 4/13/2017 10/1/2018 2/1/2019
00409-5921-01 76330DK 4/17/2017 10/1/2018 2/1/2019
mailto:[email protected]
NDC NUMBER LOT # MFG. DATE EXP DATE NEW EXP DATE
00409-5922-01 76331DK 4/18/2017 10/1/2018 2/1/2019
Extended use dates to assist with EpiPen intermittent supply interruptions
[August 21, 2018] Due to the intermittent supply interruptions of EpiPen, FDA is alerting health care professionalsand patients of updated dates through which some EpiPens and the authorized generic version, manufactured byMeridian Medical Technologies, a Pfizer company, may be used beyond the manufacturer’s labeled expiration date.To help ensure patient safety, these products should have been—and should continue to be—stored as labeled.
Based on stability data provided by Pfizer and reviewed by FDA, the following extended use dates are supported forspecific batches indicated in the tables below. Patients that have the batch numbers below will be able to use themthrough the corresponding new use dates to help with supply. As data become available, this list can continue toexpand.
FDA is not requiring or recommending that the identified batches in the following tables be relabeled with their newuse dates. However, if replacement product becomes available during the extension period, then the agency expectsthe lots in these tables will be replaced and properly disposed of as soon as possible.
Please see the recent FDA in Brief (/NewsEvents/Newsroom/FDAInBrief/ucm617724.htm) for more information,and contact CDER Drug Shortage Staff at [email protected] (mailto:[email protected])with questions regarding these tables.
Epinephrine Injection, USP 0.3 mg Auto-Injectors NDC 49502-102-02 appears on the box NDC 49502-102-01 appears on the individual device within the box
BatchManufacturer's Original Expiration Date
New Expiration Date (beyond manufacturer's original expiry date)
6FM722 4/2018 8/2018
6FM739 4/2018 8/2018
6FM771 4/2018 8/2018
6FM772 4/2018 8/2018
6FM773 4/2018 8/2018
6FM715 5/2018 9/2018
6FM716 5/2018 9/2018
6FM756 5/2018 9/2018
6FM757 5/2018 9/2018
https://www.fda.gov/NewsEvents/Newsroom/FDAInBrief/ucm617724.htmmailto:[email protected]
BatchManufacturer's Original Expiration Date
New Expiration Date (beyond manufacturer's original expiry date)
6FM768 5/2018 9/2018
6FM780 5/2018 9/2018
6FM781 5/2018 9/2018
6FM782 5/2018 9/2018
6FM783 5/2018 9/2018
6FM785 6/2018 10/2018
6FM787 6/2018 10/2018
7FM115 8/2018 12/2018
7FM117 8/2018 12/2018
7FM120 8/2018 12/2018
7FM134 8/2018 12/2018
7FM174 9/2018 1/2019
7FM175 9/2018 1/2019
7FM274 10/2018 2/2019
7FM275 10/2018 2/2019
7FM276 10/2018 2/2019
Back to Top
EpiPen® (epinephrine injection, USP) 0.3 mg Auto-Injectors NDC 49502-500-02 appears on the box NDC 49502-500-01 appears on the individual device within the box
BatchManufacturer's Original Expiration Date
New Expiration Date (beyond manufacturer's original expiry date)
6GM480 4/2018 8/2018
BatchManufacturer's Original Expiration Date
New Expiration Date (beyond manufacturer's original expiry date)
6GM481 4/2018 8/2018
6GM503 4/2018 8/2018
6GM504 4/2018 8/2018
6GM506 4/2018 8/2018
6GM507 4/2018 8/2018
6GM512 4/2018 8/2018
6GM669 4/2018 8/2018
6GM599 5/2018 9/2018
6GM685 6/2018 10/2018
6GM766 6/2018 10/2018
6GM767 6/2018 10/2018
7GM026 8/2018 12/2018
7GM045 8/2018 12/2018
7GM048 9/2018 1/2019
7GM054 9/2018 1/2019
7GM164 9/2018 1/2019
7GM172 9/2018 1/2019
7GM173 9/2018 1/2019
7GM272 9/2018 1/2019
7GM191 10/2018 2/2019
7GM200 11/2018 3/2019
7GM201 11/2018 3/2019
7GM203 12/2018 4/2019
BatchManufacturer's Original Expiration Date
New Expiration Date (beyond manufacturer's original expiry date)
7GM204 12/2018 4/2019
7GM212 12/2018 4/2019
7GM213 12/2018 4/2019
7GM360 12/2018 4/2019
7GM361 12/2018 4/2019
Back to Top
Extended use dates to assist with emergency syringe shortages
[December 21, 2018] This is to update and consolidate the information posted here previously on 6/15/17, 6/23/17,7/19/17, 8/17/17, 11/9/2017, and 6/12/2017. Due to the ongoing critical shortage of injectable drugs used in criticalcare, FDA is alerting health care professionals and emergency responders of updated dates through which some ofthese injectable drugs, manufactured by Hospira Inc, a Pfizer company, may be used beyond the manufacturer’slabeled expiration date. To help ensure patient safety, these products should have been — and should continue to be— stored as labeled.
Based on stability data provided by Pfizer and reviewed by FDA, the following extended use dates are supported forspecific lots indicated in the table below for the following products:
Atropine Sulfate Injection, USP 0.1 mg/mL; 5 mL Abboject syringe (NDC 0409-4910-34)
Atropine Sulfate Injection, USP 0.1 mg/mL; 10 mL Abboject syringe (NDC 0409-4911-34)
Atropine Sulfate Injection, USP 0.1 mg/mL; 10 mL Ansyr Plastic syringe (NDC 0409-1630-10)
Dextrose injection, USP 50% (0.5 g/mL); 25 g/50 mL Abboject syringe (NDC 0409-4902-34)
Dextrose injection, USP 50% (0.5 g/mL); 25 g/50 mL Ansyr Plastic Syringe (NDC 0409-7517-16)
Epinephrine Injection, USP 0.1 mg/mL; 10 mL Abboject syringe (NDC 0409-4921-34) (bundle of 10 syringes) andNDC 0409-4921-20 (1 syringe)
Sodium Bicarbonate Injection, USP 8.4% (1 mEq/mL); 50 mEq/50 mL Abboject Glass Syringe (18 G x 1 ½"needle) (NDC 0409-6637-34)
Hospitals that have the following lot numbers in stock will be able to use them through the corresponding new usedates to help with supply. As data become available, this list can continue to expand.
FDA is not requiring or recommending that the identified lots in the following tables be relabeled with their new usedates. However, if replacement product becomes available during the extension period, then it is expected that thelots in these tables will be replaced and properly disposed of as soon as possible.
Further information is here (https://www.fda.gov/Drugs/DrugSafety/ucm563378.htm). Please contact CDERDrug Shortage Staff at [email protected](https://www.fda.gov/Drugs/DrugSafety/DrugShortages/[email protected]) with questions
https://www.fda.gov/Drugs/DrugSafety/ucm563378.htmhttps://www.fda.gov/Drugs/DrugSafety/DrugShortages/[email protected]
regarding these tables.
Back to Top
Atropine Sulfate Injection, USP 0.1 mg/mL; 5 mL ABBOJECT syringe (NDC0409-4910-34)
Product/ Lot Number
Manufacturer’s Original Expiry Date
New Use Date (beyond manufacturer’s originalexpiry date)
67331DK00 1-Jul-2018 1-Jan-2019
69292DK00 1-Sep-2018 1-Mar-2019
Back to Top
Atropine Sulfate Injection, USP 0.1 mg/mL; 10 mL ABBOJECT syringe (NDC0409-4911-34)
Product/ Lot Number
Manufacturer’s Original Expiry Date
New Use Date (beyond manufacturer’s originalexpiry date)
62470DK00 1-Feb-2018 1-Feb-2019
63292DK00 1-Mar-2018 1-Mar-2019
63293DK00 1-Mar-2018 1-Mar-2019
63318DK00 1-Mar-2018 1-Mar-2019
63319DK00 1-Mar-2018 1-Mar-2019
64271DK00 1-Apr-2018 1-Apr-2019
64301DK00 1-Apr-2018 1-Apr-2019
64302DK00 1-Apr-2018 1-Apr-2019
65255DK00 1-May-2018 1-May-2019
66267DK00 1-Jun-2018 1-Jun-2019
67259DK00 1-Jul-2018 1-Jul-2019
67302DK00 1-Jul-2018 1-Jul-2019
71343DK00 1-Nov-2018 1-Nov-2019
74033DK00 1-Feb-2019 1-Feb-2020
77115DK00 1-May-2019 1-May-2020
77194DK00 1-May-2019 1-May-2020
77237DK00 1-May-2019 1-May-2020
77238DK00 1-May-2019 1-May-2020
77320DK00 1-May-2019 1-May-2020
Back to Top
Atropine Sulfate Injection, USP 0.1 mg/mL; 10 mL Ansyr Plastic syringe (NDC0409-1630-10)
Product/ Lot Number
Manufacturer’s Original Expiry Date
New Use Date (beyond manufacturer’s originalexpiry date)
68327EV00 1-Aug-2018 1-Feb-2019
68328EV00 1-Aug-2018 1-Feb-2019
68439EV00 1-Aug-2018 1-Feb-2019
68440EV00 1-Aug-2018 1-Feb-2019
70046EV00 1-Oct-2018 1-Apr-2019
70047EV00 1-Oct-2018 1-Apr-2019
70048EV00 1-Oct-2018 1-Apr-2019
70049EV00 1-Oct-2018 1-Apr-2019
71130EV00 1-Nov-2018 1-May-2019
71197EV00 1-Nov-2018 1-May-2019
71319EV00 1-Nov-2018 1-May-2019
75406EV00 1-Mar-2019 1-Sep-2019
75407EV00 1-Mar-2019 1-Sep-2019
75408EV00 1-Mar-2019 1-Sep-2019
75409EV00 1-Mar-2019 1-Sep-2019
77031EV00 1-May-2019 1-Nov-2019
77033EV00 1-May-2019 1-Nov-2019
77034EV00 1-May-2019 1-Nov-2019
77068EV00 1-May-2019 1-Nov-2019
Back to Top
Dextrose 50% Injection, USP, 50 mL ABBOJECT Syringe (NDC 0409-4902-34)
Product/ Lot Number
Manufacturer’s Original Expiry Date
New Use Date (beyond manufacturer’s originalexpiry date)
63391DK00 1-Mar-2018 1-Mar-2019
63392DK00 1-Mar-2018 1-Mar-2019
63475DK00 1-Mar-2018 1-Mar-2019
64278DK00 1-Apr-2018 1-Apr-2019
64282DK00 1-Apr-2018 1-Apr-2019
65468DK00 1-May-2018 1-May-2019
66007DK00 1-Jun-2018 1-Jun-2019
66387DK00 1-Jun-2018 1-Jun-2019
67040DK00 1-Jul-2018 1-Jul-2019
67041DK00 1-Jul-2018 1-Jul-2019
67042DK00 1-Jul-2018 1-Jul-2019
68082DK00 1-Aug-2018 1-Aug-2019
68458DK00 1-Aug-2018 1-Aug-2019
77099DK00 1-May-2019 1-May-2020
77224DK00 1-May-2019 1-May-2020
77226DK00 1-May-2019 1-May-2020
77232DK00 1-May-2019 1-May-2020
77402DK00 1-May-2019 1-May-2020
Back to Top
Dextrose injection 50% (0.5 g/mL); 25 g/50 mL Ansyr Plastic Syringe (NDC0409-7517-16)
Product/ Lot Number
Manufacturer’s Original Expiry Date
New Use Date (beyond manufacturer’s originalexpiry date)
67171EV00 1-Jul-2018 1-Jan-2019
67329EV00 1-Jul-2018 1-Jan-2019
68009EV00 1-Aug-2018 1-Feb-2019
68010EV00 1-Aug-2018 1-Feb-2019
68011EV00 1-Aug-2018 1-Feb-2019
68187EV00 1-Aug-2018 1-Feb-2019
68188EV00 1-Aug-2018 1-Feb-2019
68189EV00 1-Aug-2018 1-Feb-2019
68190EV00 1-Aug-2018 1-Feb-2019
69098EV00 1-Sep-2018 1-Mar-2019
69099EV00 1-Sep-2018 1-Mar-2019
69100EV00 1-Sep-2018 1-Mar-2019
69101EV00 1-Sep-2018 1-Mar-2019
69102EV00 1-Sep-2018 1-Mar-2019
69188EV00 1-Sep-2018 1-Mar-2019
69189EV00 1-Sep-2018 1-Mar-2019
69190EV00 1-Sep-2018 1-Mar-2019
69191EV00 1-Sep-2018 1-Mar-2019
69192EV00 1-Sep-2018 1-Mar-2019
70189EV00 1-Oct-2018 1-Apr-2019
70190EV00 1-Oct-2018 1-Apr-2019
70191EV00 1-Oct-2018 1-Apr-2019
70192EV00 1-Oct-2018 1-Apr-2019
71190EV00 1-Nov-2018 1-May-2019
71191EV00 1-Nov-2018 1-May-2019
71192EV00 1-Nov-2018 1-May-2019
71193EV00 1-Nov-2018 1-May-2019
71323EV00 1-Nov-2018 1-May-2019
71324EV00 1-Nov-2018 1-May-2019
71325EV00 1-Nov-2018 1-May-2019
71326EV00 1-Nov-2018 1-May-2019
72102EV00 1-Dec-2018 1-Jun-2019
72103EV00 1-Dec-2018 1-Jun-2019
72104EV00 1-Dec-2018 1-Jun-2019
72105EV00 1-Dec-2018 1-Jun-2019
73059EV00 1-Jan-2019 1-Jul-2019
73060EV00 1-Jan-2019 1-Jul-2019
73061EV00 1-Jan-2019 1-Jul-2019
73062EV00 1-Jan-2019 1-Jul-2019
73140EV00 1-Jan-2019 1-Jul-2019
74055EV00 1-Feb-2019 1-Aug-2019
74056EV00 1-Feb-2019 1-Aug-2019
74057EV00 1-Feb-2019 1-Aug-2019
74380EV00 1-Feb-2019 1-Aug-2019
74381EV00 1-Feb-2019 1-Aug-2019
74382EV00 1-Feb-2019 1-Aug-2019
75135EV00 1-Mar-2019 1-Sep-2019
75268EV00 1-Mar-2019 1-Sep-2019
75269EV00 1-Mar-2019 1-Sep-2019
75270EV00 1-Mar-2019 1-Sep-2019
76186EV00 1-Apr-2019 1-Oct-2019
76187EV00 1-Apr-2019 1-Oct-2019
76188EV00 1-Apr-2019 1-Oct-2019
76189EV00 1-Apr-2019 1-Oct-2019
76316EV00 1-Apr-2019 1-Oct-2019
77036EV00 1-May-2019 1-Nov-2019
77037EV00 1-May-2019 1-Nov-2019
77038EV00 1-May-2019 1-Nov-2019
Back to Top
Epinephrine Injection, USP 0.1 mg/mL; 10 mL ABBOJECT syringe (NDC 0409-4921-34) (bundle of 10 syringes) and (NDC 0409-4921-20) (1 syringe)
Product/ Lot Number
Manufacturer’s Original Expiry Date
New Use Date (beyond manufacturer’s originalexpiry date)
67016DK00 1-Apr-2018 1-Jan-2019
67075DK00 1-Apr-2018 1-Jan-2019
67076DK00 1-Apr-2018 1-Jan-2019
67078DK00 1-Apr-2018 1-Jan-2019
67079DK00 1-Apr-2018 1-Jan-2019
67080DK00 1-Apr-2018 1-Jan-2019
67081DK00 1-Apr-2018 1-Jan-2019
67085DK00 1-Apr-2018 1-Jan-2019
67086DK00 1-Apr-2018 1-Jan-2019
67087DK00 1-Apr-2018 1-Jan-2019
67088DK00 1-Apr-2018 1-Jan-2019
68086DK00 1-May-2018 1-Feb-2019
68087DK00 1-May-2018 1-Feb-2019
68090DK00 1-May-2018 1-Feb-2019
68091DK00 1-May-2018 1-Feb-2019
68092DK00 1-May-2018 1-Feb-2019
68094DK00 1-May-2018 1-Feb-2019
68096DK00 1-May-2018 1-Feb-2019
68097DK00 1-May-2018 1-Feb-2019
68098DK00 1-May-2018 1-Feb-2019
68155DK00 1-May-2018 1-Feb-2019
68156DK00 1-May-2018 1-Feb-2019
68316DK00 1-May-2018 1-Feb-2019
68317DK00 1-May-2018 1-Feb-2019
68398DK00 1-May-2018 1-Feb-2019
69171DK00 1-Jun-2018 1-Mar-2019
69172DK00 1-Jun-2018 1-Mar-2019
69273DK00 1-Jun-2018 1-Mar-2019
69274DK00 1-Jun-2018 1-Mar-2019
69278DK00 1-Jun-2018 1-Mar-2019
70265DK00 1-Jul-2018 1-Apr-2019
76158DK00 1-Jan-2019 1-Oct-2019
76159DK00 1-Jan-2019 1-Oct-2019
77113DK00 1-Feb-2019 1-Nov-2019
77114DK00 1-Feb-2019 1-Nov-2019
77117DK00 1-Feb-2019 1-Nov-2019
77118DK00 1-Feb-2019 1-Nov-2019
77195DK00 1-Feb-2019 1-Nov-2019
77196DK00 1-Feb-2019 1-Nov-2019
77197DK00 1-Feb-2019 1-Nov-2019
77240DK00 1-Feb-2019 1-Nov-2019
77241DK00 1-Feb-2019 1-Nov-2019
77242DK00 1-Feb-2019 1-Nov-2019
77408DK00 1-Feb-2019 1-Nov-2019
Back to Top
Sodium Bicarbonate Injection, USP 8.4% (1 mEq/mL); 50 mEq/50 mL AbbojectGlass Syringe (18 G x 1 ½" needle (NDC 0409-6637-34))
Product/ Lot Number
Manufacturer’s Original Expiry Date
New Use Date (beyond manufacturer’s originalexpiry date)
67045DK00 1-Jul-2018 1-Jan-2019
67046DK00 1-Jul-2018 1-Jan-2019
67047DK00 1-Jul-2018 1-Jan-2019
68040DK00 1-Aug-2018 1-Feb-2019
68041DK00 1-Aug-2018 1-Feb-2019
68079DK00 1-Aug-2018 1-Feb-2019
68080DK00 1-Aug-2018 1-Feb-2019
68336DK00 1-Aug-2018 1-Feb-2019
68405DK00 1-Aug-2018 1-Feb-2019
68406DK00 1-Aug-2018 1-Feb-2019
68407DK00 1-Aug-2018 1-Feb-2019
69128DK00 1-Sep-2018 1-Mar-2019
69129DK00 1-Sep-2018 1-Mar-2019
69131DK00 1-Sep-2018 1-Mar-2019
69132DK00 1-Sep-2018 1-Mar-2019
69133DK00 1-Sep-2018 1-Mar-2019
69134DK00 1-Sep-2018 1-Mar-2019
69142DK00 1-Sep-2018 1-Mar-2019
69144DK00 1-Sep-2018 1-Mar-2019
69270DK00 1-Sep-2018 1-Mar-2019
69271DK00 1-Sep-2018 1-Mar-2019
69346DK00 1-Sep-2018 1-Mar-2019
69395DK00 1-Sep-2018 1-Mar-2019
69396DK00 1-Sep-2018 1-Mar-2019
69397DK00 1-Sep-2018 1-Mar-2019
70351DK00 1-Oct-2018 1-Apr-2019
73127DK00 1-Jan-2019 1-Jul-2019
73128DK00 1-Jan-2019 1-Jul-2019
73129DK00 1-Jan-2019 1-Jul-2019
73337DK00 1-Jan-2019 1-Jul-2019
74344DK00 1-Feb-2019 1-Aug-2019
76026DK00 1-Apr-2019 1-Oct-2019
76027DK00 1-Apr-2019 1-Oct-2019
76028DK00 1-Apr-2019 1-Oct-2019
76029DK00 1-Apr-2019 1-Oct-2019
76074DK00 1-Apr-2019 1-Oct-2019
76297DK00 1-Apr-2019 1-Oct-2019
76301DK00 1-Apr-2019 1-Oct-2019
76302DK00 1-Apr-2019 1-Oct-2019
76368DK00 1-Apr-2019 1-Oct-2019
77101DK00 1-May-2019 1-Nov-2019
77102DK00 1-May-2019 1-Nov-2019
77103DK00 1-May-2019 1-Nov-2019
77106DK00 1-May-2019 1-Nov-2019
77107DK00 1-May-2019 1-Nov-2019
77108DK00 1-May-2019 1-Nov-2019
77227DK00 1-May-2019 1-Nov-2019
77228DK00 1-May-2019 1-Nov-2019
77230DK00 1-May-2019 1-Nov-2019
77233DK00 1-May-2019 1-Nov-2019
77234DK00 1-May-2019 1-Nov-2019
77235DK00 1-May-2019 1-Nov-2019
78194DK00 1-Jun-2019 1-Dec-2019
78195DK00 1-Jun-2019 1-Dec-2019
78238DK00 1-Jun-2019 1-Dec-2019
78241DK00 1-Jun-2019 1-Dec-2019
78242DK00 1-Jun-2019 1-Dec-2019
78243DK00 1-Jun-2019 1-Dec-2019
78326DK00 1-Jun-2019 1-Dec-2019
Back to Top
Drug Shortages: Additional News and Information (/Drugs/DrugSafety/DrugShortages/ucm349561.htm)
Frequently Asked Questions about Drug Shortages (/Drugs/DrugSafety/DrugShortages/ucm050796.htm)
Drug Shortages Infographic (/Drugs/DrugSafety/DrugShortages/ucm441579.htm)
More in Drug Shortages(/Drugs/DrugSafety/DrugShortages/default.htm)
https://www.fda.gov/Drugs/DrugSafety/DrugShortages/ucm349561.htmhttps://www.fda.gov/Drugs/DrugSafety/DrugShortages/ucm050796.htmhttps://www.fda.gov/Drugs/DrugSafety/DrugShortages/ucm441579.htmhttps://www.fda.gov/Drugs/DrugSafety/DrugShortages/default.htm